Erste Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Erste Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-127,800	Closed	-$5.91M	–	460
2019 Q2	$5.91M	Buy	127,800 +22,800	+22%	+$640K	0.31%	86
2019 Q1	$2.49M	Sell	105,000 -14,200	-12%	-$296K	0.14%	150
2018 Q4	$1.72M	Buy	+119,200	New	+$1.81M	0.12%	173

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Erste Asset Management's ARRY Position: Q3 2019 in Review

Erste Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 127,800 shares — an estimated $5.91M sold.

Erste Asset Management first reported a position in ARRY in Q4 2018 and held it in 3 quarters. The position peaked at $5.91M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Erste Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Erste Asset Management sold 127,800 Array Biopharma Inc shares in Q3 2019, an estimated $5.91M.
Erste Asset Management first reported a position in Array Biopharma Inc in Q4 2018 and held it in 3 quarters.
Erste Asset Management's Array Biopharma Inc position peaked at $5.91M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Erste Asset Management's 13F filing for Q3 2019, filed 22 Nov 2024.